/PRNewswire/ PatientPoint® today announced the addition of Jeffrey Vacirca, MD, FACP, and Amy Grogg, PharmD, to its board of directors. Dr. Vacirca will.
Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.